Literature DB >> 27891331

Association of Diabetic Nephropathy and Liver Disorders.

Usha Sachidananda Adiga1, B N Malawadi2.   

Abstract

INTRODUCTION: Liver disorder is known to be a risk factor for Diabetes Mellitus (DM) and diabetic patients are at risk of developing liver disorders. Association of liver and renal disease is less explored in the field of research; hence, we conducted a retrospective study on this. AIM: To compare the renal and liver profiles of type II DM patients compared to healthy controls and find the association between the two profiles in diabetics.
MATERIALS AND METHODS: The renal and liver profiles of 68 type II DM patients and 58 controls were compared. Estimated Glomerular Filtration Rate (GFR) (eGFR) was calculated using Modification of Diet in Renal Disease (MDRD) formula and was taken as a tool to grade different stages of diabetic nephropathy. Comparison of liver profiles between different stages of diabetic nephropathy was done. Correlations and associations were studied between eGFR and liver enzymes and Bilirubin.
RESULTS: A significant elevation in Total Bilirubin (TB) (p< 0.15), Direct Bilirubin (DB) (p< 0.0035), Aspartate Amino Transferase (AST) and Alanine Amino Transferase (ALT) (p<0.0001) levels in diabetics was noted. An elevated eGFR and a significant correlation between eGFR and liver enzymes were observed. A significant association between liver and renal disease has been obtained in diabetics (p=0.0136).
CONCLUSION: Significantly, high liver function tests and low eGFR were observed in type II diabetics. A significant positive correlation between liver enzymes (AST and ALT) and eGFR suggest a possible association between liver and kidney functions in DM.

Entities:  

Keywords:  Bilirubin; Estimated glomerular filtration rate; Liver enzymes; Type 2 diabetes mellitus

Year:  2016        PMID: 27891331      PMCID: PMC5121669          DOI: 10.7860/JCDR/2016/21672.8728

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  15 in total

1.  Assessing kidney function--measured and estimated glomerular filtration rate.

Authors:  Lesley A Stevens; Josef Coresh; Tom Greene; Andrew S Levey
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

2.  Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients.

Authors:  G Targher; L Bertolini; M Chonchol; S Rodella; G Zoppini; G Lippi; L Zenari; E Bonora
Journal:  Diabetologia       Date:  2010-04-06       Impact factor: 10.122

3.  Liver pathology in morbidly obese patients with and without diabetes.

Authors:  J F Silverman; K F O'Brien; S Long; N Leggett; P G Khazanie; W J Pories; H T Norris; J F Caro
Journal:  Am J Gastroenterol       Date:  1990-10       Impact factor: 10.864

4.  Correlations between serum bilirubin levels and diabetic nephropathy progression among Japanese type 2 diabetic patients: a prospective cohort study (Diabetes Distress and Care Registry at Tenri [DDCRT 5]).

Authors:  Tsuyoshi Mashitani; Yasuaki Hayashino; Shintarou Okamura; Satoru Tsujii; Hitoshi Ishii
Journal:  Diabetes Care       Date:  2013-09-05       Impact factor: 19.112

Review 5.  Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study.

Authors:  M Trombetta; G Spiazzi; G Zoppini; M Muggeo
Journal:  Aliment Pharmacol Ther       Date:  2005-11       Impact factor: 8.171

6.  Evaluation of liver function in type 2 diabetic patients during clinical trials: evidence that rosiglitazone does not cause hepatic dysfunction.

Authors:  Harold E Lebovitz; Margaret Kreider; Martin I Freed
Journal:  Diabetes Care       Date:  2002-05       Impact factor: 19.112

7.  Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients.

Authors:  G Targher; L Bertolini; S Rodella; G Zoppini; G Lippi; C Day; M Muggeo
Journal:  Diabetologia       Date:  2007-12-06       Impact factor: 10.122

Review 8.  Nonalcoholic steatohepatitis: a study of 49 patients.

Authors:  R G Lee
Journal:  Hum Pathol       Date:  1989-06       Impact factor: 3.466

9.  Inverse association between serum bilirubin levels and arterial stiffness in Korean women with type 2 diabetes.

Authors:  Eun Sook Kim; Eun Young Mo; Sung Dae Moon; Je Ho Han
Journal:  PLoS One       Date:  2014-10-09       Impact factor: 3.240

10.  Non-Alcoholic Fatty Liver Disease Is a Risk Factor for the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus.

Authors:  Guoyu Jia; Fusheng Di; Qipeng Wang; Jinshuang Shao; Lei Gao; Lu Wang; Qiang Li; Nali Li
Journal:  PLoS One       Date:  2015-11-13       Impact factor: 3.240

View more
  5 in total

1.  Role of metabolizing MTHFR gene polymorphism (rs1801133) and its mRNA expression among Type 2 Diabetes.

Authors:  Divya Pathak; Dharmsheel Shrivastav; Amit K Verma; Abdulrahman A Alsayegh; Prasant Yadav; Nawaid Hussain Khan; Alhanouf I Al-Harbi; Mohammad Idreesh Khan; Kapil Bihade; Desh Deepak Singh; Mirza Masroor Ali Beg
Journal:  J Diabetes Metab Disord       Date:  2022-02-19

2.  Antidiabetic Potency, Antioxidant Effects, and Mode of Actions of Citrus reticulata Fruit Peel Hydroethanolic Extract, Hesperidin, and Quercetin in Nicotinamide/Streptozotocin-Induced Wistar Diabetic Rats.

Authors:  Alaa M Ali; Mohamed Abdel Gabbar; Sanaa M Abdel-Twab; Eman M Fahmy; Hossam Ebaid; Ibrahim M Alhazza; Osama M Ahmed
Journal:  Oxid Med Cell Longev       Date:  2020-06-20       Impact factor: 6.543

3.  Clinical, Laboratory, Instrumental, Anamnestic Characteristics in Children With Type I Diabetes Mellitus and Early Stage of Diabetic Nephropathy.

Authors:  Ievgeniia A Burlaka; Inga O Mityuryayeva; Tetiana A Shevchenko; Anastasiia D Holoborodko; Ihor V Kovalchuk; Lilia O Lantukh
Journal:  Glob Pediatr Health       Date:  2021-12-22

4.  Retrospective study of factors associated with progression and remission/regression of diabetic kidney disease-hypomagnesemia was associated with progression and elevated serum alanine aminotransferase levels were associated with remission or regression.

Authors:  Tatsuo Yanagawa; Keiko Koyano; Koichiro Azuma
Journal:  Diabetol Int       Date:  2021-01-02

5.  The fat mass, estimated glomerular filtration rate, and chronic inflammation in type 2 diabetic patients.

Authors:  Tomáš Šálek; Alena Adamíková; Petr Ponížil
Journal:  J Clin Lab Anal       Date:  2020-02-11       Impact factor: 2.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.